ARCHIVES

BMS, Exelixis To Collaborate On Drug Development.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011